查詢結果分析
來源資料
相關文獻
- 桂枝茯苓丸加黑木耳方對於肥胖性多發性卵巢囊腫症候群的臨床初步療效評估
- The Effectiveness of Metformin Therapy in Women with Polycystic Ovary Syndrome
- 多囊性卵巢症候群
- 高胰島素血症在卵巢雄性素過多症所扮演的角色
- 多囊性卵巢症新觀念
- Spontaneous Hyperinsulinism-Diagnosis and Localization in 13 cases
- 抗糖尿病藥物在多囊性卵巢症候群之應用
- Persistent Hyperinsulinemic Hypoglycemia of Infancy: A Case Report
- 高胰島素血症與高血壓之致病機轉
- Risk Factors for Hyperinsulinemia in Chlorpropamide-Treated Diabetic Patients : A Three-Year Follow-up
頁籤選單縮合
題 名 | 桂枝茯苓丸加黑木耳方對於肥胖性多發性卵巢囊腫症候群的臨床初步療效評估=Clinical Trial of Gui-Zhi-Fu-Ling-Wan and Auricularia Polytricha Formula in the Treatment of Obese Polycystic Ovary Syndrome. Preliminary Clinical Therapeutics |
---|---|
作 者 | 陳彥霖; 李耀泰; 翁紹評; 施景中; 鄭鴻祥; 陳啟楨; | 書刊名 | 臺灣中醫醫學雜誌 |
卷 期 | 5:1 民95.06 |
頁 次 | 頁75-94 |
分類號 | 413.61 |
關鍵詞 | 桂枝茯苓丸加黑木耳方; 調經肥胖; 多發性卵巢囊腫; 雄性素過多; 高胰島素; Gui-zhi-fu-ling-wan and auricularia polytricha formula; Menstrual cycle obesity; PCOS; Hyperandrogenism; Hyperinsulinemia; |
語 文 | 中文(Chinese) |
中文摘要 | 多囊性卵巢症候群(po1ycystic ovary syndrome; PCOS)影響女性從青春期到更年期,是女性不孕的主因,如果放任不治療,易導致肥胖,糖尿病,心臟病及子宮內膜癌。且多數患者對metformin治療效果不滿意,希望有其他更好的療法,所以尋求其它有效而方便的藥物是急迫的需要。為證實桂枝茯苓丸加黑木耳方對於多發性卯巢囊腫症候群肥胖者減重調經及降血脂之療效,本試驗採用雙盲隨機、對照方式進行,研究對象以郭綜合醫院中醫科,婦產科門診之PCOS肥胖病人BMI>27kg/平方公尺為主,並符合PCOS納入排除標準之患者,72位隨機分為兩組:桂枝茯苓丸加黑木耳方(A組)及安慰劑(B組)。AB兩組每位患者每次給予15g藥粉包每日三次。每位患者每週看診一次記錄臨床變化,26週後抽血檢查生化數據。結果,治療前後比較,本方在月經週期(Menstrual index)的縮短及血清睪固酮(Testosterone)降低均有顯著的意義,腰圍減少2.45±1.40公分(P<0.001),BMI減少1.66±0.72(kg/平方公尺)(P<0.001);生化值方面,桂枝茯苓丸加黑木耳方治療前後三酸甘油脂減少9.48mg/dl、膽固醇減少15.55mg/dl、收縮壓減少6.77mmHg、舒張壓減少4.90mmHg飯前血糖降低4.87mg/dl,皆達顯著意義(P<0.001)。 |
英文摘要 | Polycystic ovarian syndrome indiscriminately strikes women between the ages of puberty and menopause. It is the leading cause of female infertility, and if left untreated can lead to obesity, diabetes, heart disease, and endometrial cancer. Although metformin therapy have been some beneficial effects in PCOS patient, further investigation and controlled studies are necessary to evaluate long-term effect. A number of reports show that Chinese herbs improve menstrual function, however, only few studies have been placebo-controlled. The aim of our study was to use a double blind, placebo-controlled, approach with assessment of menstrual function and BMI reduction. All of 72 Chinese women with obese polycystic ovary syndrome (PCOS) were randomized to receive Gui-zhi-fu-ling-wan and Auricularia polytricha Formula or placebo with l5g three times daily for 6 months. Anthropometric, endocrine, and ovarian ultrasound assessments were effected before and after 6 months treatment. Gui-zhi-fu-ling-wan and Auricularia polytricha Formula treatment, resulted in a significant decrease in Menstrual index, BMI, body weight, and Testosterone (p<0.0001), as well as also decrease in triglycerides, and low-density lipoprotein (LDL). Gui-zhi-fu-ling-wan and Auricularia polytricha Formula is well tolerated by the majority of patients and may be clinically useful as an alternative treatment for metformin, particularly in patients having obese PCOS and menstrual disturbances. |
本系統中英文摘要資訊取自各篇刊載內容。